Learning Objectives

  • Review the association between inherited thrombophilia and recurrent miscarriage

  • Discuss key evidence informing anticoagulation use and pregnancy outcomes in women with inherited thrombophilia and recurrent miscarriage

A 32-year-old woman was referred to you at 15 weeks gestation regarding anticoagulation management. She has a history of 2 prior miscarriages at weeks 12 and 15, and she reports that she has a homozygous prothrombin gene mutation (PGM). She denies any personal or family history of venous thromboembolism. How would you approach anticoagulation in this patient?

Recurrent pregnancy loss (RPL) affects 1%-5% of couples, placing a significant psychological and physical burden on women and families and increasing health care costs. The etiology for RPL remains unexplained in half of the cases despite extensive evaluation, and physicians and patients resort to treatment modalities that have uncertain benefit in an attempt to achieve...

1.
El Hachem
H
,
Crepaux
V
,
May-Panloup
P
,
Descamps
P
,
Legendre
G
,
Bouet
P-E
.
Recurrent pregnancy loss: current perspectives
.
Int J Womens Health
.
2017
;
9
:
331
-
345
.
2.
Robertson
L
,
Wu
O
,
Langhorne
P
, et al
;
Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study
.
Thrombophilia in pregnancy: a systematic review
.
Br J Haematol
.
2006
;
132
(
2
):
171
-
196
.
3.
Vossen
CY
,
Preston
FE
,
Conard
J
, et al.
Hereditary thrombophilia and fetal loss: a prospective follow-up study
.
J Thromb Haemost
.
2004
;
2
(
4
):
592
-
596
.
4.
Rodger
MA
,
Betancourt
MT
,
Clark
P
, et al.
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies
.
PLoS Med
.
2010
;
7
(
6
):
e1000292
.
5.
Liu
X
,
Chen
Y
,
Ye
C
, et al.
Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis
.
Hum Reprod
.
2021
;
36
(
5
):
1213
-
1229
.
6.
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins–Obstetrics
.
ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy
.
Obstet Gynecol
.
2018
;
132
(
1
):
e18
-
e34
.
7.
Middeldorp
S
.
Anticoagulation in pregnancy complications
.
Hematology Am Soc Hematol Educ Program
.
2014
;
2014
(
1
):
393
-
399
.
8.
Bates
SM
,
Greer
IA
,
Middeldorp
S
,
Veenstra
DL
,
Prabulos
A-M
,
Vandvik
P-O
.
VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
.
Chest
.
2012
;
141
(
2 suppl
):
e691S
-
e736S
.
9.
Bates
SM
,
Rajasekhar
A
,
Middeldorp
S
, et al.
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy
.
Blood Adv
.
2018
;
2
(
22
):
3317
-
3359
.
10.
Grandone
E
,
Tiscia
GL
,
Mastroianno
M
, et al.
Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry
.
Hum Reprod
.
2021
;
36
(
8
):
2083
-
2090
.
11.
Rodger
MA
,
Hague
WM
,
Kingdom
J
, et al
;
TIPPS
Investigators
.
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
.
Lancet
.
2014
;
384
(
9955
):
1673
-
1683
.
12.
de Jong
PG
,
Kaandorp
S
,
Di Nisio
M
,
Goddijn
M
,
Middeldorp
S
.
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia
.
Cochrane Database Syst Rev
.
2014
;
2014
(
7
):
CD004734
.
13.
Chen
Y
,
Wang
T
,
Liu
X
, et al.
Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: a systematic review and meta-analysis
.
J Obstet Gynaecol Res
.
2022
;
48
(
8
):
2134
-
2150
.
14.
Skeith
L
,
Carrier
M
,
Kaaja
R
, et al.
A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia
.
Blood
.
2016
;
127
(
13
):
1650
-
1655
.
15.
Leaf
RK
,
Connors
JM
.
The role of anticoagulants in the prevention of pregnancy complications
.
Clin Appl Thromb Hemost
.
2017
;
23
(
2
):
116
-
123
.
16.
Quenby
S
,
Booth
K
,
Hiller
L
, et al
;
ALIFE2 Block Writing Committee
;
ALIFE2 Investigators
.
Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial
.
Lancet
.
2023
;
402
(
10395
):
54
-
61
.
17.
ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy
.
Obstet Gynecol
.
2018
;
132
(
1
):
e44
-
e52
.
You do not currently have access to this content.